A number of other equities research analysts have also recently weighed in on the company. Jefferies Financial Group cut ASPEN PHARMACAR/ADR from a “buy” rating to a “hold” rating in a research note on Thursday. Zacks Investment Research lowered ASPEN PHARMACAR/ADR from a “hold” rating to a “sell” rating in a research note on Monday, November 18th.
Shares of OTCMKTS:APNHY opened at $7.43 on Friday. ASPEN PHARMACAR/ADR has a 12-month low of $4.14 and a 12-month high of $11.36. The business’s fifty day simple moving average is $7.54 and its 200-day simple moving average is $6.56.
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products.
Recommended Story: Dividend
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for ASPEN PHARMACAR/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASPEN PHARMACAR/ADR and related companies with MarketBeat.com's FREE daily email newsletter.